Exelixis Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 29 Posts
1 2
E Boris Bounce; Trump Tripwire
Article By: Vivian Lewis Sunday, December 15, 2019 5:30 PM EDT
Boris Johnson beat the pollsters handily and Britain went into holiday mode. Meanwhile back on Capitol Hill, the on-again-off-again trade deal with China was on again on. The drug price limits bill is dead in the water which will boost pharma stocks.
In this article: BLRX, LLY, RHHBY, EXEL, GSK, BVNRY, CZZ, IRL, MXE, NOK, SLB, MXCHF, NPSNY, TCEHY, HOLI, AQN, PROSY
Read
The 5 Top Biotech Stocks To Buy For 2020
Article By: Money Morning Thursday, October 31, 2019 6:25 AM EDT
As an investor, it pays to know who benefits the most from our elected officials. In 2019, that has been particularly true for biotech stocks.
In this article: JAZZ, LGND, EXEL, INVA, VNDA
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
Profiting From Changes In Stock Personality
Article By: Marc Gerstein Wednesday, November 28, 2018 11:32 PM EDT
Do stocks have personalities? Yes, they do, and we all know it even though we may not explicitly use that language when we think or talk about stocks.
In this article: ALEX, BK, CPF, NLS, PBI, PHM, TPC, SGA, TREE, EXEL, EGBN, GOGO, HRTG, HY Also: WMT, TSLA, SPY
Read
Trump Announces Plan To Reign In Drug Prices And Pharma Stocks Rally
Article By: Zacks Investment Research Sunday, May 13, 2018 11:37 AM EDT
President Trump unveiled his plan to control US drug prices. Stock prices of the biggest drug companies briefly declined, only to reverse course and ended the day broadly higher. The reason? The plan doesn’t seem to be “taking them on” at all.
In this article: LLY, MRK, AMGN, EXEL, ABBV
Read
Bull Of The Day: Exelixis
Article By: Kevin Cook Friday, May 11, 2018 9:55 AM EDT
Unique among small biotech companies, EXEL is a profitable mid-cap cancer fighter with projected 58% revenue growth and 68% EPS growth this year.
In this article: EXEL
Read
Exelixis, Roche Slide After Colon Cancer Drug Fails To Meet Primary Study Goal
Article By: The Fly Thursday, May 10, 2018 12:50 PM EDT
Shares of Exelixis and partner Roche are under pressure this morning after the companies announced that the Phase 3 IMblaze370 trial did not achieve statistical-significance on the primary efficacy endpoint.
In this article: RHHBY, EXEL Also: BMY, MRK, ARRY
Read
4 Biotech Stocks To Watch In The New Year
Article By: Zacks Investment Research Sunday, January 7, 2018 5:23 PM EDT
Biotech companies are continuously working on bringing innovative new treatments to market, and there could be significant catalysts in the coming quarters in the form of important product approvals as well as major data read-outs.
In this article: EBS, GSK, MDCO, XOMA, EXEL, NVS, MLNT
Read
Exelixis Surges After Cabometyx Granted Priority Review, Meets Endpoint In Trial
Article By: The Fly Monday, October 16, 2017 12:50 PM EDT
Shares of Exelixis jumped in early trading after the biopharmaceutical company said it received priority review from the U.S. Food and Drug Administration for a treatment for advanced renal cell carcinoma.
In this article: EXEL Also: IPSEY, BAYRY
Read
4 Stocks To Buy With Superb Earnings Acceleration
Article By: Zacks Investment Research Monday, February 27, 2017 2:14 PM EDT
Earnings growth captivates almost everyone, right from the top brass to research analysts. This is simply because earnings are a measure of the money a company is making.
In this article: RES, EXEL, INTU, SLCA
Read
Day Trading Stock Picks For This Week - Tuesday, Feb. 21
Article By: Cory Mitchell, CMT Tuesday, February 21, 2017 9:11 AM EDT
The stock list this week includes: CLF, AKS, SGYP, CYH, DYN, ENDP, X, EXEL, CDE, WFT and AG.
In this article: CLF, AKS, SGYP, CYH, DYN, ENDP, X, EXEL, CDE, WFT, AG
Read
Day Trading Stock Picks For This Week - Tuesday, Feb. 14
Article By: Cory Mitchell, CMT Tuesday, February 14, 2017 8:23 AM EDT
The stock list this week includes: CLF, AKS, SGYP, CDE, X, AG, EXEL, DYN and WFT.
In this article: AG, AKS, CDE, CLF, DYN, SGYP, WFT, X, EXEL
Read
5 Drug Stocks Poised To Beat Earnings Estimates In Q4
Article By: Arpita Dutt Thursday, February 9, 2017 11:11 AM EDT
A positive earnings picture continues to emerge from the fourth-quarter earnings season with both earnings and revenue growth improving compared to recent quarters.
In this article: EXEL, INCY, JAZZ, IRWD, AKAO
Read
5 Great Biotech Stocks To Buy Now
Article By: Swarup Gupta Tuesday, February 7, 2017 5:45 PM EDT
Biotechs have recovered substantially from the losses they suffered up to early last year. Adding biotech stocks to your portfolio looks like a smart option at this point.
In this article: CELG, CLLS, EXEL, EXAS, SNSS Also: BMRN
Read
Day Trading Stock Picks For This Week - Tuesday, Jan. 17
Article By: Cory Mitchell, CMT Tuesday, January 17, 2017 10:50 AM EDT
The stock list this week includes: SGYP, CLF, ASNA, TWLO, AG, AKS, WFT, EXEL, CDE, CYH, X and HL.
In this article: CYH, HL, X, EXEL, CDE, WFT, AKS, ASNA, TWLO, AG, CLF, SGYP
Read
4 Biotech Stocks That More Than Doubled In 2016
Article By: Arpita Dutt Thursday, December 22, 2016 11:47 AM EDT
2016 has not been a great year for biotech stocks, which were under intense pressure with issues like increasing political and media focus on high price tags for drugs, and the changing competitive scenario weighing on the sector.
In this article: CLCD, EXEL, TSRO, AKAO
Read
1 to 16 of 29 Posts
1 2